Understanding Mild/Moderate SCN8A
February 24, 2024 @ 3:00 pm – 5:00 pm MST
Explore the nuances and unique challenges faced by children with mild to moderate SCN8A impacts, facilitated by AI-assisted language translation. Connect with other families on similar journeys, gain insights into research updates, and find resources tailored to this specific SCN8A category. Engage with Dr. Hammer and a broader community dedicated to offering support and understanding.
We would like to extend our thanks to Neurocrine Biosciences and Praxis Precision Medicines for their support of these meetings which bring improved quality of life to families and allows them opportunities to learn, connect, and contribute to the understanding of SCN8A.